Management of type 2 diabetes, obesity, or nonalcoholic steatohepatitis with high‐dose GLP‐1 receptor agonists and GLP‐1 receptor‐based co‐agonists

2型糖尿病 医学 利拉鲁肽 非酒精性脂肪肝 胰高血糖素样肽1受体 脂肪性肝炎 肥胖 糖尿病 脂肪肝 胰高血糖素样肽-1 内科学 生物信息学 药理学 内分泌学 受体 疾病 兴奋剂 生物
作者
Ronald Goldenberg,Jeremy Gilbert,Priya Manjoo,Sue D. Pedersen,Vincent Woo,Julie A. Lovshin
出处
期刊:Obesity Reviews [Wiley]
卷期号:25 (3) 被引量:2
标识
DOI:10.1111/obr.13663
摘要

Summary Type 2 diabetes (T2D), obesity, and nonalcoholic fatty liver disease/nonalacoholic steatohepatitis (NAFLD/NASH) share mutual causalities. Medications that may offer clinical benefits to all three conditions are being developed. Glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs) are approved for the management of T2D and obesity and there is great interest in evaluating higher doses of available GLP‐1RAs and developing novel GLP‐1RA‐based co‐agonists to provide greater reductions in glycated hemoglobin (HbA1c) and body weight as well as modifying NAFLD/NASH complications in clinically meaningful ways. High‐dose GLP‐1RAs and multi‐hormonal strategies including GLP‐1R agonism have either already been approved or are in development for managing T2D, obesity, or NASH. We provide a mechanistic outline with a detailed summary of the available clinical data and ongoing trials that are adjudicating the impact of high‐dose GLP‐1RAs, unimolecular, and multimolecular GLP‐1R‐based co‐agonists in populations living with T2D, obesity, or NASH. The available trial findings are aligned with preclinical observations, showing clinical efficacy and safety thus providing optimism for the expansion of GLP‐1R‐based drug classes for managing the triad of T2D, obesity and NASH. Development, access, and wide‐spread utilization of these new therapeutic approaches will offer important opportunities to markedly improve the collective global burden of T2D, obesity, and NASH.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
LLLL完成签到 ,获得积分10
1秒前
2秒前
orixero应助nicelily采纳,获得10
5秒前
真实的枕头完成签到,获得积分10
5秒前
过时的芸发布了新的文献求助10
6秒前
time完成签到,获得积分10
7秒前
7秒前
8秒前
龙disco完成签到,获得积分10
8秒前
莫名乐乐完成签到,获得积分10
9秒前
10秒前
合适雅绿完成签到,获得积分10
10秒前
CHSLN完成签到 ,获得积分10
14秒前
辛勤尔白完成签到 ,获得积分10
14秒前
邱同学完成签到,获得积分10
14秒前
张小小发布了新的文献求助10
15秒前
ChatGPT发布了新的文献求助10
15秒前
慕青应助yoowt采纳,获得10
16秒前
脑洞疼应助yoowt采纳,获得10
16秒前
无花果应助yoowt采纳,获得10
16秒前
Akim应助yoowt采纳,获得10
16秒前
Jasper应助yoowt采纳,获得10
16秒前
所所应助yoowt采纳,获得10
16秒前
研友_VZG7GZ应助yoowt采纳,获得10
17秒前
星辰大海应助StarkGavin采纳,获得10
17秒前
英姑应助yoowt采纳,获得10
17秒前
赘婿应助yoowt采纳,获得10
17秒前
脑洞疼应助yoowt采纳,获得10
17秒前
koh完成签到,获得积分10
18秒前
学呀学发布了新的文献求助10
19秒前
充电宝应助伍仨仨采纳,获得10
19秒前
卓涵柏发布了新的文献求助10
20秒前
25秒前
wanci应助drift采纳,获得10
26秒前
29秒前
29秒前
郝剑身发布了新的文献求助30
30秒前
34秒前
牛太虚发布了新的文献求助200
34秒前
Stan771完成签到,获得积分10
36秒前
高分求助中
Sustainability in Tides Chemistry 1500
TM 5-855-1(Fundamentals of protective design for conventional weapons) 1000
CLSI EP47 Evaluation of Reagent Carryover Effects on Test Results, 1st Edition 800
Threaded Harmony: A Sustainable Approach to Fashion 799
Livre et militantisme : La Cité éditeur 1958-1967 500
Retention of title in secured transactions law from a creditor's perspective: A comparative analysis of selected (non-)functional approaches 500
"Sixth plenary session of the Eighth Central Committee of the Communist Party of China" 400
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3055707
求助须知:如何正确求助?哪些是违规求助? 2712333
关于积分的说明 7431052
捐赠科研通 2357290
什么是DOI,文献DOI怎么找? 1248745
科研通“疑难数据库(出版商)”最低求助积分说明 606786
版权声明 596144